for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

WHO sets dates for reviews of Sinopharm and Sinovac COVID-19 vaccines

GENEVA, April 22 (Reuters) - Technical experts at the World Health Organization (WHO) will review on April 26 Chinese drugmaker Sinopharm’s COVID-19 vaccine for possible emergency use listing, to be followed by the Sinovac jab on May 3, the agency said on Thursday.

“We would expect a decision a couple of days later,” the WHO said in response to a Reuters query.

So far COVID-19 vaccines made by Pfizer AstraZeneca and Johnson & Johnson have received a WHO listing - an endorsement of their safety and efficacy that helps to guide countries’ regulatory agencies.

Reporting by Stephanie Nebehay Editing by David Goodman

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up